Longxin Listing Looms: History Shows A-Shares Typically Weather Large IPOs Within Weeks
As Longxin's public listing draws near, investors are chiefly worried about one thing: will massive IPOs drain liquidity and drag down the broader market? Tianfeng Securities examined historical patterns around major A-shares IPOs since 2005 — and the data rejects the simple narrative that "big listing equals market selloff."
The V-Shape Recovery Pattern Is Real
In a May 31 strategy note, analyst Wu Kaida laid out the core finding: broad indices like the CSI All-Index tend to compress gains ahead of a large IPO, dip in the first post-listing week, and then snap back — a short-lived V-shaped pullback rather than a sustained downturn. Crucially, in most historical windows, the probability of positive returns stayed above 50%.
Structural dispersion is the real story. The CSI 300 and CSI 500 recover quickly, while smaller indices — the CSI 2000, ChiNext, and Sci-Tech Innovation Index — feel the squeeze for far longer. Style-wise, growth and consumer sectors rebound more forcefully than defensive financial plays.
This means the IPO debate should move beyond the "bloodletting" framing. History shows capital disruption is real but time-limited; what really matters is whether the prevailing market theme, sector sentiment, and style rotation can absorb the shock — not the listing itself.
Pressure Arrives Fast, Departs Fast
Using a sample of IPOs raising over ¥1 billion since 2005, the CSI All-Index consistently follows this sequence: gains compress from +4.66% to +0.43% in the final pre-listing weeks, turn negative at -0.51% in the first seven trading sessions after listing, then recover to roughly +0.76% by weeks three to four.
Win rates reinforce this picture. The CSI All-Index stays above 50% at every stage, even hitting 60% in the 14 and 7 trading days before listing. In other words, large IPOs function as a short-term tempering mechanism, not a trend-reversal signal.
Booms and Peaks Cluster Together
A-shares IPOs are deeply cyclical. Two peaks stand out:
| Period | Peak Year | Key Players |
|---|---|---|
| 2007–2010 | 2007 (¥476B raised) | State-owned banks, energy giants |
| 2020–2023 | 2022 (¥587B raised) | STAR Market tech, select SOEs |
The 2007 wave featured China Petroleum, Shenhua Energy, and CCB all listing near the Shanghai Composite's 6,124-point record. After 2020, SMIC, China Mobile, and BeiGene went public — tech-driven names on an entirely different market. Large offerings cluster during enthusiasm, not stagnation.
Small-Cap Stocks Bear the Brunt
CSI 300, 500, and 1000 indices mirror the broad index's V-shape. The CSI 2000, ChiNext, and Sci-Tech Innovation Index are another story — larger drawdowns persist through day 28, with recovery lagging large and mid-cap peers.
Win rates tell the tale clearly:
- Tech indices (ChiNext, Sci-Tech): only 33–40% win rate in the first week post-IPO
- Large-cap indices: win rate dips but reclaims 50%+ by day 14
- Mid/small-cap: 50–60% win rates pre-IPO, peak at 7 days before listing
Liquidity-sensitive, high-valuation segments suffer disproportionately — not because of fundamentals, but because capital temporarily rotates toward the new listing.
Style Rotation After IPOs: Growth Wins, Finance Lags
Growth and consumption indices post the strongest rebounds after the first-week dip, reaching +1.74% and +1.68% respectively by day 28. Cyclical sectors hold steady above 50% win rate throughout. Financial indices, often assumed to be the safe haven, recover only to +0.39% — the weakest performer.
This directly challenges the assumption that large IPOs trigger a flight to defensive assets. Historically, growth and consumer names lead the recovery, not financial defensive plays.
Sector Case Studies: Capital Rotation Isn't Destiny
During the 2007 wave, construction and engineering stocks bounced back most aggressively — +11.00% by day 28 after initial weakness. Petrochemicals, however, never recovered, ending at -22.11% by day 28.
In the 2021 tech listing wave, electronics recovered to +7.99% by day 28, while biopharma lagged at -3.03%. The lesson: short-term capital rotation does not overwrite medium-term sector fundamentals. If the tech narrative holds, pressure is temporary; if a sector lacks staying power, the IPO merely accelerates an existing weakness.
What Longxin Means for the Market Right Now
Applying historical context to Longxin: expect capital disruption in the immediate window, with initial market caution. But broad indices are unlikely to stay under sustained pressure — recovery probability is historically non-trivial.
The genuine risks are structural, not cyclical. Small-cap, high-valuation, and liquidity-sensitive segments face the longest drag. Large and mid-cap assets absorb the shock more gracefully. Style-wise, growth and consumer have shown the strongest historical recovery — finance has not benefited from "IPO defensiveness."
The "Sai Dian 2.0" Phase 3 push faces friction and volatility, but AI remains the defining theme. Longxin's listing is better read as a liquidity stress test than a directional market signal — one that reveals underlying vulnerabilities but does not, by itself, alter the trend.
评论栏